Department Of Endocrinology 1
1. FRUCTOSAMINE VALUES IN MONITORING COMPENSATION AND EFFICACY OF DIABETES MELLITUS TREATMENT
2. The Importance of Fructosamine for Monitoring the Compensation and Effectiveness of Diabetes Treatment
3. Global multi-societies endorsement of the MAFLD definition
4. Global multi-societies endorsement of the MAFLD definition
5. Reduced insulin use and diabetes complications upon introduction of SGLT-2 inhibitors and GLP1-receptor agonists in low- and middle-income countries: A microsimulation
6. Post-COVID syndrome and type 2 diabetes mellitus in Kazakhstan: clinical manifestations and vaccine efficacy
7. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
8. Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan
9. Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan
10. Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan
11. Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan
12. Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan
13. ISPAD Clinical Practice Consensus Guidelines 2022: Ramadan and other religious fasting by young people with diabetes
14. Genotype-phenotype association in congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children
15. Genotype-phenotype association in congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children
16. Epitopes specificity of antibodies to thyroid peroxidase in patients with Graves’ disease, Hashimotos thyroiditis and overlap-syndrome
17. The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
18. Access to prediabetes care: A SAFES statement
19. Access to prediabetes care: A SAFES statement
20. Access to prediabetes care: A SAFES statement
21. Access to prediabetes care: A SAFES statement
22. Access to prediabetes care: A SAFES statement
23. Access to prediabetes care: A SAFES statement
24. Access to prediabetes care: A SAFES statement
25. Access to prediabetes care: A SAFES statement
26. Access to prediabetes care: A SAFES statement
27. Access to prediabetes care: A SAFES statement
28. The prevalence of diabetes mellitus in Kazakhstan: A systematic review and meta-analysis
29. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
30. Immunohistochemical analysis of ghrelin expression in various types of adrenal tumors
31. Development of a Fuzzy Diagnostic Model of Ischemic Disease of the Lower Limbs for Different Stages of Patient Management
32. Differential Diagnosis of Pancreatic Cancer and Chronic Pancreatitis According to Endoscopic Ultrasonography Based on the Analysis of the Nature of the Contours of Focal Formations Based on Fuzzy Mathematical Models
33. Fuzzy Models of Choice of Prevention Schemes for the Occurrence and Development of Gangrene of the Lower Extremities
34. Method for Determining the Body’s Level of Protection According to Oxidant Status in Assessing the Influence of Industrial Risk Factors on Health
35. Association of plasminogen activator inhibitor-1 and cardiovascular events development in patients with prediabetes
36. Advancing the global public health agenda for NAFLD: a consensus statement
37. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
38. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021
39. The Contribution of Genetic Variants to the Risk of Papillary Thyroid Carcinoma in the Kazakh Population: Study of Common Single Nucleotide Polymorphisms and Their Clinicopathological Correlations
40. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
41. Changes in Insulin Resistance with Different Weight Loss Methods in Patients with Type Two Diabetes Mellitus and Hypertension: A Comparative Clinical Trial
42. Weight loss treatment for COVID-19 in patients with NCDs: a pilot prospective clinical trial
43. Role of ethnic and genetic factors in the development of prostate cancer (Review)
44. The first experience of using a comprehensive detailed ultrasound examination of the foot in patients with diabetes mellitus
45. A Cross-Sectional Analysis of Maternal Cardiac Autonomic Function in Kazakh Pregnant Women with Gestational Diabetes
46. Mapping routine measles vaccination in low- and middle-income countries
47. Influence of Chain Length of Gradient and Block Copoly(2-oxazoline)s on Self-Assembly and Drug Encapsulation
48. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study
49. Biological response of adrenal carcinoma and melanoma cells to mitotane treatment
50. Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000–2023: a systematic analysis from the Global Burden of Disease Study 2023
1 2